Glucose News and Research

RSS

Majority of Medicaid patients on antipsychotic drugs do not undergo metabolic tests, says study

Despite government warnings and professional recommendations about diabetes risks associated with second-generation antipsychotic drugs, fewer than one-third of Medicaid patients who are treated with these medications undergo tests of blood glucose or lipid levels, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Jan 2010

Headline results from first phase III study of Balaglitazone announced

Dr. Reddy’s Laboratories Ltd. and Rheoscience, a subsidiary of Nordic Bioscience A/S, today announced the headline results from the first phase III study for their investigational agent, Balaglitazone.

4 Jan 2010

Biodel submits NDA to FDA for clearance to market VIAject

Biodel, Inc. announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for clearance to market VIAject® as a treatment for diabetes.

30 Dec 2009

Pharmacists can reduce treatment costs and improve outcomes if given the chance

The role of pharmacists hasn't received much attention in the debate on the cost of health care. But national and regional studies show that when pharmacists directly participate in patient care, they significantly reduce treatment costs and improve outcomes.

30 Dec 2009

ADA recommends the A1C test for diabetes screening and diagnosis

New official guidelines for diabetes screening and diagnosis now include a blood test that gives a person's average blood glucose level over the previous 2-3 months.

30 Dec 2009

TheScientist honors Seahorse Bioscience's XF96 Extracellular Flux Analyzer as a 2009 Top Ten Innovation

Seahorse Bioscience, Inc., leader in the design and development of instruments for measuring cellular bioenergetics, announced that TheScientist magazine cited their XF96 Extracellular Flux Analyzer as a 2009 Top Ten Innovation.

30 Dec 2009

Study suggests genetic variations predispose African-Americans to diabetes

For years, scientists have tried to determine the basis for discrepancies between race and the predisposition for development of diseases such as type II diabetes and cardiovascular disease. Could factors such as differences in lifestyle or access to health care play a role, or is there something else in play?

29 Dec 2009

American Diabetes Association recommends A1C test for diagnosing diabetes and identifying pre-diabetes

The American Diabetes Association's new Clinical Practice Recommendations being published as a supplement to the January issue of Diabetes Care call for the addition of the A1C test as a means of diagnosing diabetes and identifying pre-diabetes. The test has been recommended for years as a measure of how well people are doing to keep their blood glucose levels under control.

29 Dec 2009

Cholesterol expert offers simple resolutions and advice for staying heart healthy in New Year

Family physician and cholesterol expert Michael Cobble, M.D., has some simple resolutions and fun advice for staying heart healthy in the new year. Cobble is a board-certified clinical lipidologist (NLA), certified hypertension specialist (ASH), medical director of the private practice Canyons Medical Center in Sandy, Utah, and Chief Medical Officer at Atherotech, Inc., developer of the VAP Cholesterol Test.

29 Dec 2009

Discovery of beta cell defending enzyme raises hope for new treatments against diabetes

Cells in your body are constantly churning out poisonous forms of oxygen (oxidants) and mopping them up with a countervailing force of proteins and chemicals (anti-oxidants).

28 Dec 2009

Steroids not superior to laser treatments for DME

Researchers led by specialists at the Johns Hopkins Wilmer Eye Institute have found that injecting a corticosteroid, triamcinolone, directly into the eye may slow the progression of proliferative diabetic retinopathy, a complication of diabetes that frequently leads to blindness.

27 Dec 2009

Cardiac marker POC test: A successful concept of point-of-care diagnostics

Cardiac marker POC tests are now widely used in hospitals and have emerged as a successful model of the concept of point-of-care diagnostics, according to a new report from Kalorama Information. The 2008 world market for POC cardiac enzymes and tests is estimated at $490 million, and growing at 12% a year for the past three years, according to "Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads," from healthcare market research publisher Kalorama Information.

24 Dec 2009

Intervention strategy brings positive changes in type 2 diabetic patients

South Dakota State University research showed an intervention strategy based on the Native American spiritual concept of the Medicine Wheel brought positive changes for diabetics.

24 Dec 2009

Reduced calories increase human cell lifespan

Going back for a second dessert after your holiday meal might not be the best strategy for living a long, cancer-free life say researchers from the University of Alabama at Birmingham. That's because they've shown exactly how restricted calorie diets-specifically in the form of restricted glucose-help human cells live longer. This discovery, published online in The FASEB Journal (http://www.fasebj.org) could help lead to drugs and treatments that slow human aging and prevent cancer.

23 Dec 2009

High prevalence of type 2 diabetes may be linked to excess niacin intake

Facing the increasing prevalence of type 2 diabetes worldwide in the past few decades, one may ask what is wrong with humans. Geneticists tell us that the human genome has not changed markedly in such a short time.

23 Dec 2009

Monitoring blood glucose levels with contact lenses may soon be a reality for diabetes patients

Diabetics may soon be able to wear contact lenses that continuously alert them to variations in their glucose levels by changing colours - replacing the need to routinely draw blood throughout the day.

22 Dec 2009

Medical students from TCOM offer health screening for homeless

Medical students from the Texas College of Osteopathic Medicine (TCOM) offered a health screening for the homeless Friday, Dec. 11, in an effort to give back to the people of Tarrant County.

22 Dec 2009

Cost outweighs benefits of self-monitoring blood glucose test strips

Routine self-monitoring of blood glucose levels by people with type 2 diabetes who are not taking insulin is an ineffective use of health resources as the modest benefits are outweighed by the significant cost of test strips, suggest 2 studies http://www.cmaj.ca/embargo/cmaj091017.pdf and http://www.cmaj.ca/embargo/cmaj090765.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca .

22 Dec 2009

CPEX Pharmaceuticals completes enrollment in Nasulin Phase 2a clinical trial

CPEX Pharmaceuticals, Inc. today announced that the ongoing Phase 2a clinical trial of Nasulin™, the Company’s intranasal insulin candidate, has now completed enrollment. The study was initiated in February of this year and randomized 94 subjects. Results are expected at the end of the first quarter or beginning of the second quarter of 2010.

21 Dec 2009

Bran flakes with raisins and added sugar promote plaque acid

Elevated dental plaque acid is a risk factor that contributes to cavities in children. But eating bran flakes with raisins containing no added sugar does not promote more acid in dental plaque than bran flakes alone, according to new research at the University of Illinois at Chicago.

19 Dec 2009